N
IGMS

Nuveen’s IGM Biosciences IGMS Stock Holding History

Nuveen’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-45,015
Closed -$51.8K – 3323
2025
Q1 		$51.8K Hold
45,015
– – ﹤0.01% 3257
2024
Q4 		$275K Hold
45,015
– – ﹤0.01% 3145
2024
Q3 		$745K Buy
45,015
+4,266
+10% +$46.7K ﹤0.01% 2874
2024
Q2 		$280K Hold
40,749
– – ﹤0.01% 3167
2024
Q1 		$393K Sell
40,749
-9,074
-18% -$105K ﹤0.01% 3037
2023
Q4 		$414K Sell
49,823
-29,364
-37% -$171K ﹤0.01% 3069
2023
Q3 		$661K Hold
79,187
– – ﹤0.01% 2745
2023
Q2 		$731K Sell
79,187
-1,982
-2% -$22.2K ﹤0.01% 2794
2023
Q1 		$1.11M Sell
81,169
-1,935
-2% -$40K ﹤0.01% 2574
2022
Q4 		$1.41M Buy
83,104
+37,920
+84% +$759K ﹤0.01% 2528
2022
Q3 		$1.03M Sell
45,184
-42,505
-48% -$858K ﹤0.01% 2740
2022
Q2 		$1.58M Buy
87,689
+61,277
+232% +$1.09M ﹤0.01% 2557
2022
Q1 		$420K Buy
26,412
+2,530
+11% +$47.1K ﹤0.01% 3063
2021
Q4 		$700K Sell
23,882
-7,074
-23% -$352K ﹤0.01% 2975
2021
Q3 		$2.04M Sell
30,956
-8,651
-22% -$662K ﹤0.01% 2666
2021
Q2 		$3.29M Buy
39,607
+6,747
+21% +$500K ﹤0.01% 2466
2021
Q1 		$2.52M Buy
32,860
+3,230
+11% +$294K ﹤0.01% 2509
2020
Q4 		$2.62M Sell
29,630
-22,223
-43% -$1.56M ﹤0.01% 2373
2020
Q3 		$3.83M Sell
51,853
-2,693
-5% -$159K ﹤0.01% 2059
2020
Q2 		$3.98M Buy
54,546
+35,350
+184% +$2.15M ﹤0.01% 2025
2020
Q1 		$1.08M Buy
19,196
+11,378
+146% +$499K ﹤0.01% 2488
2019
Q4 		$298K Buy
+7,818
New +$196K ﹤0.01% 3014

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Nuveen's IGMS Position: Q2 2025 in Review

Nuveen sold out of IGM Biosciences (IGMS) in Q2 2025, closing a stake of 45,015 shares — an estimated $51.8K sold.

Nuveen first reported a position in IGMS in Q4 2019 and held it in 22 quarters. The position peaked at $3.98M in Q2 2020. 66 funds tracked by Wall St. Rank hold IGMS as of Q2 2025.

  • Nuveen reported no remaining IGM Biosciences position as of Q2 2025 after selling out during the quarter.
  • Nuveen sold 45,015 IGM Biosciences shares in Q2 2025, an estimated $51.8K.
  • Nuveen first reported a position in IGM Biosciences in Q4 2019 and held it in 22 quarters.
  • Nuveen's IGM Biosciences position peaked at $3.98M in Q2 2020.
  • 66 funds tracked by Wall St. Rank held IGM Biosciences as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.